| Announce Date | 10/30/2025 |
| EPS Normalized Actual | $0.68 (Beat by $0.31) |
| EPS GAAP Actual | $0.68 (Beat by $0.31) |
| Revenue Actual | $0.030491B |
| Revenue Surprise | Beat by $30.491M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.68 |
| EPS GAAP Estimate | $0.68 |
| Revenue Estimate | $0.03B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 2.09 | 15.42 | 2.09 | 2.09 | 1 |
| Dec 2025 | 2.1 | 15.35 | 2.1 | 2.1 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.68 | 0.1 | 0.030491B | 4.42% | 2.49M |
| FQ2 2025 (Jun 2025) | 0.61 | 0.03 | 0.028549B | 3.97% | 0.55M |
| FQ1 2025 (Mar 2025) | 0.53 | 0.09 | 0.025886B | 5.18% | 0.89M |
| FQ4 2024 (Dec 2024) | 0.37 | -0.28 | 0.02685B | 8.58% | -2.15M |
| FQ3 2024 (Sep 2024) | 0.66 | 0.11 | 0.029142B | 8.83% | 2.14M |
| FQ2 2024 (Jun 2024) | 0.52 | -0.82259 | 0.027416B | 7.9% | -23.09M |
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 0.024544B | 8.35% | 24.54M |
| FQ4 2023 (Dec 2023) | 0.34 | 0.34 | 0.024545B | -2.33% | 24.55M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.68
Consensus Revenue Estimates
0.03B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.41 | -- | 0.41 | 0.41 | 1 |
| FQ3 2026 (Sep 2026) | 0.75 | 9.33 | 0.75 | 0.75 | 1 |
| FQ2 2026 (Jun 2026) | 0.58 | -5.17 | 0.58 | 0.58 | 1 |
| FQ1 2026 (Mar 2026) | 0.35 | -51.43 | 0.35 | 0.35 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.03B | -- | 0.03B | 0.03B | 1 |
| FQ3 2026 (Sep 2026) | 0.03B | 4.72 | 0.03B | 0.03B | 1 |
| FQ2 2026 (Jun 2026) | 0.03B | 4.84 | 0.03B | 0.03B | 1 |
| FQ1 2026 (Mar 2026) | 0.03B | 0.44 | 0.03B | 0.03B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
2
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.58 | 0.68 | 0.1 | 14.71% |
| FQ2 2025 (Jun 2025) | 0.58 | 0.61 | 0.03 | 4.92% |
| FQ1 2025 (Mar 2025) | 0.44 | 0.53 | 0.09 | 16.98% |
| FQ4 2024 (Dec 2024) | 0.65 | 0.37 | -0.28 | -75.68% |
| FQ3 2024 (Sep 2024) | 0.55 | 0.66 | 0.11 | 16.67% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.52 | -0.82259 | -158.19% |
| FQ1 2024 (Mar 2024) | 0.43 | 0.43 | 100% | |
| FQ4 2023 (Dec 2023) | 0.34 | 0.34 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.03B | $0.03B | $2.49M | 8.17% |
| FQ2 2025 (Jun 2025) | $0.03B | $0.03B | $0.55M | 1.92% |
| FQ1 2025 (Mar 2025) | $0.03B | $0.03B | $0.89M | 3.42% |
| FQ4 2024 (Dec 2024) | $0.03B | $0.03B | $-2.15M | -8.01% |
| FQ3 2024 (Sep 2024) | $0.03B | $0.03B | $2.14M | 7.35% |
| FQ2 2024 (Jun 2024) | $0.05B | $0.03B | $-23.09M | -84.21% |
| FQ1 2024 (Mar 2024) | $0B | $0.02B | $24.54M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.02B | $24.55M | 100% |